Foret-Bruno, P;
Shafran, R;
Stephenson, T;
Nugawela, MD;
Chan, D;
Ladhani, S;
McOwat, K;
Mensah, A;
Simmons, R;
Fox Smith, L;
et al.
Foret-Bruno, P; Shafran, R; Stephenson, T; Nugawela, MD; Chan, D; Ladhani, S; McOwat, K; Mensah, A; Simmons, R; Fox Smith, L; D'oelsnitz, A; Xu, L; Dalrymple, E; Heyman, I; Ford, T; Segal, T; Chalder, T; Rojas, N; Pinto Pereira, SM; CLoCk Consortium
(2024)
Prevalence and co-occurrence of cognitive impairment in children and young people up to 12-months post infection with SARS-CoV-2 (Omicron variant).
Brain Behav Immun, 119.
pp. 989-994.
ISSN 0889-1591
https://doi.org/10.1016/j.bbi.2024.05.001
SGUL Authors: Ladhani, Shamez Nizarali
![]() |
PDF
Published Version
Available under License Creative Commons Attribution. Download (449kB) |
Abstract
BACKGROUND: Cognitive impairment is often reported after SARS-CoV-2 infection, yet evidence gaps remain. We aimed to (i) report the prevalence and characteristics of children and young people (CYP) reporting "brain fog" (i.e., cognitive impairment) 12-months post PCR-proven SARS-CoV-2 infection and determine whether differences by infection status exist and (ii) explore the prevalence of CYP experiencing cognitive impairment over a 12-month period post-infection and investigate the relationship between cognitive impairment and poor mental health and well-being, mental fatigue and sleep problems. METHODS: The Omicron CLoCk sub-study, set up in January 2022, collected data on first-time PCR-test-positive and PCR-proven reinfected CYP at time of testing and at 3-, 6- and 12-months post-testing. We describe the prevalence of cognitive impairment at 12-months, indicating when it was first reported. We characterise CYP experiencing cognitive impairment and use chi-squared tests to determine whether cognitive impairment prevalence varied by infection status. We explore the relationship between cognitive impairment and poor mental health and well-being, mental fatigue and trouble sleeping using validated scales. We examine associations at 3-, 6- and 12-months post-testing by infection status using Mann-Whitney U and chi-square tests. RESULTS: At 12-months post-testing, 7.0 % (24/345) of first-positives and 7.5 % (27/360) of reinfected CYP experienced cognitive impairment with no difference between infection-status groups (p = 0.78). The majority of these CYP experienced cognitive impairment for the first time at either time of testing or 3-months post-test (no difference between the infection-status groups; p = 0.60). 70.8 % of first-positives experiencing cognitive impairment at 12-months, were 15-to-17-years-old as were 33.3 % of reinfected CYP experiencing cognitive impairment (p < 0.01). Consistently at all time points post-testing, CYP experiencing cognitive impairment were more likely to score higher on all Strengths and Difficulties Questionnaire subscales, higher on the Chalder Fatigue sub-scale for mental fatigue, lower on the Short Warwick-Edinburgh Mental Wellbeing Scale and report more trouble sleeping. CONCLUSIONS: CYP have a fluctuating experience of cognitive impairment by 12-months post SARS-CoV-2-infection. Cognitive impairment is consistently correlated with poorer sleep, behavioural and emotional functioning over a 12-month period. Clinicians should be aware of cognitive impairment post-infection and its co-occurring nature with poorer sleep, behavioural and mental health symptoms.
Item Type: | Article | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Additional Information: | © 2024 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). | ||||||||||||||||||
Keywords: | Brain fog, Children, Cognitive impairment, Omicron, Post Covid-19 condition, Prospective, Young people, long Covid, Humans, COVID-19, Cognitive Dysfunction, Male, Female, Adolescent, Child, Prevalence, SARS-CoV-2, Sleep Wake Disorders, Young Adult, Mental Fatigue, Mental Health, Child, Preschool | ||||||||||||||||||
SGUL Research Institute / Research Centre: | Academic Structure > Infection and Immunity Research Institute (INII) | ||||||||||||||||||
Journal or Publication Title: | Brain Behav Immun | ||||||||||||||||||
ISSN: | 0889-1591 | ||||||||||||||||||
Language: | eng | ||||||||||||||||||
Media of Output: | Print-Electronic | ||||||||||||||||||
Related URLs: | |||||||||||||||||||
Publisher License: | Creative Commons: Attribution 4.0 | ||||||||||||||||||
Projects: |
|
||||||||||||||||||
PubMed ID: | 38735404 | ||||||||||||||||||
Go to PubMed abstract | |||||||||||||||||||
URI: | https://openaccess.sgul.ac.uk/id/eprint/117567 | ||||||||||||||||||
Publisher's version: | https://doi.org/10.1016/j.bbi.2024.05.001 |
Statistics
Actions (login required)
![]() |
Edit Item |